


Sacral Nerve Stimulation devices are anticipated to grow the fastest with CAGR of 18.7% from 2015 to 2019. Increasing incidence of fecal and urinary incontinence in North America and Europe is a significant growth driver for this device segment. The rise in incidence subsequently has been estimated largely aided by the aging population in the developed regions.
North America continued to lead global incontinence care products and devices market with a share of 32.0% in 2014